Your browser doesn't support javascript.
loading
Efficacy and safety of selinexor-based regimens for relapsed/refractory multiple myeloma: a systematic review of literature.
Masood, Adeel; Iqbal, Qamar; Ehsan, Hamid; Davis, James A; Hansen, Doris K; Hashmi, Hamza.
Affiliation
  • Masood A; University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. adeelmasood100@gmail.com.
  • Iqbal Q; Internal Medicine - Tidal Health Peninsula Regional, 100 East Carroll Street, Salisbury, MD, 21801, USA.
  • Ehsan H; Levine Cancer Institute/Atrium Health, 1021 Morehead Medical Drive, Charlotte, NC, 28262, USA.
  • Davis JA; Hematology/Oncology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC, 29425, USA.
  • Hansen DK; Department of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), H. Lee Moffitt Cancer Center and Research Institute, 12902 USF Magnolia Drive, Tampa, FL, 33612, USA.
  • Hashmi H; Hematology/Oncology, Medical University of South Carolina, 171 Ashley Ave, Charleston, SC, 29425, USA.
Ann Hematol ; 101(12): 2601-2610, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36214853
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Systematic_reviews Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Systematic_reviews Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2022 Document type: Article Affiliation country: Country of publication: